Biologics
Improving biologics process development, control, and comparability with Multiplexing Optical Methods
Explore how Multiplexing Optical Methods (MOM™) and Prometheus Panta C help drive Quality by Design (QbD) through process control, comparability studies, and lifecycle management in biologics.
How to identify critical quality attributes and define design space in biologics using Multiplexing Optical Methods
A data-driven approach to Quality by Design (QbD): Learn how to identify CQAs and define design space in biologics development using Multiplexing Optical Methods (MOM™) and Prometheus Panta.
Guide: Prometheus Panta Parameters Explained
This guide provides an overview of the key analytical parameters obtained with Prometheus Panta, their definitions and practical relevance for protein characterization and drug development.
Powering Precision: How Automated Analytical Devices are Driving Smarter Biomanufacturing
Learn about Prometheus Panta C: A next-generation stability characterization platform that's helping biomanufacturers bring automation into the analytical core of their development and process control
Unfolding insights: How nanoDSF is reshaping biotherapeutics development at Johnson & Johnson Innovative Medicine
Dr. Marius Müller of Johnson & Johnson Innovative Medicine shares insights from questions about the use of nanoDSF™ technology for ID-testing and at several late stages of biotherapeutics development.
NanoTemper Announces Prometheus Panta C: Powering Biopharma Breakthroughs from Preclinical to Commercial Manufacturing
NanoTemper Technologies announces the launch of Prometheus Panta C, a solution designed to meet the evolving needs of biopharmaceutical development—from preclinical phase to commercial manufacturing.
3 trends shaping the future of Biomanufacturing
Expert Marius Müller, PhD, Team Lead at Johnson & Johnson Innovative Medicine, shares insights into three significant trends that have potential to reshape the biopharma and biomanufacturing industry
Pushing Boundaries in Biophysics and Biomanufacturing
Marius, a biophysics expert at Johnson & Johnson Innovative Medicine, shares his insights into this rapidly evolving field of biomanufacturing.
Trying to select the best candidates for biologics development?
A combination of thermal and colloidal stability characterization will help
Boost Your Lab's Performance: 3 Ways to Increase Efficiency with Prometheus Panta
Learn how to enhance your lab's efficiency with Prometheus Panta, from using capillary chips for high-throughput sample loading to solutions for seamless integration in automated workflows
Learn how to select and optimize your biologic candidates for better clinical outcomes
Read more
31:28nanoDSF as an efficient, high-throughput method for ID testing in biologics manufacturing
Watch this webinar to discover how Dr. Marius Müller from Johnson & Johnson Innovative Medicine, uses nanoDSF, a high-throughput method that assesses protein stability, for drug substance ID testing.
5 biologics conferences you won’t want to miss in 2025
Use this curated list of must-attend 2025 biologics conferences to plan your year. Find out when and where each conference takes place, who will be there, and what you can expect.
26:58How Immunocore tackles formulation development and delivery challenges for novel bispecifics
Watch this webinar about approaches and insights into bispecific formulation development and screening with Prometheus Panta for thermal and colloidal stability characterization of biotherapeutics.
38:20Conversation: How Aaron Frimel from Thermo Fisher Scientific approaches biologics formulation
Join this conversation to gain insight into how the Analytical and Formulation Sciences team at Thermo Fisher Scientific approaches stability assessment of biologic, and how the Prometheus Panta helps
5 types of formulation excipients and how they impact biologics stability
Each excipient class helps stabilize biologics – from monoclonal antibodies to vaccine antigens – in different ways. Read on to learn more about some of the most important excipients for...
22:59Biologics Formulation: Select optimal buffer conditions with multi-parameter stability characterization from Prometheus Panta
Learn how to identify optimal buffer conditions during pre-formulation, with multi-parameter stability characterization from Prometheus Panta, a tool to collect thermal and colloidal data while saving
How Pierre Fabre Laboratories enhances their antibody developability platform
Learn how Pierre Fabre uses multi-parameter stability measurements of mAb libraries on Prometheus Panta to streamline developability platforms, reducing complexity, cost, and sample consumption.
Why Dr. Elsa Wagner from Pierre Fabre chose Prometheus Panta for mAbs developability assessment
Read why scientist Dr. Elsa Wagner chose the Prometheus Panta instrument with simultaneous measurements of DLS, nanoDSF, SLS and backreflection for developability assessment of their mAbs candidates.
16:24De-risk your antibody characterization workflows with high-quality, multi-parameter stability data from Prometheus Panta
Get developability profiles for monoclonal antibodies with stability data from Prometheus Panta to inform on rational design and selection of therapeutic constructs that will succeed in the clinic.
Trying to select the best candidates for biologics development?
A combination of thermal and colloidal stability characterization will help
5 considerations for buffer optimization during biologics pre-formulation
The work of pre-formulations scientists is critical to de-risk the entire development process for biologics. Read on to learn more about what to consider about your buffer components for...
Learn how to select and optimize your biologic candidates for better clinical outcomes
Read more
17:08Assess the impact of bioconjugation with multi-parameter stability characterization
Characterize the developability of antibody-drug conjugates: Multi-parameter stability assessment with Prometheus Panta makes it possible to examine multiple aspects of ADC stability in parallel.
